Corrigendum to ‘Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III cl

Authors

SubbaReddy Gunneri
Subhash Thuluva (ORCID: https://orcid.org/0000-0002-9099-420X)
Rammohan Reddy Mogulla (ORCID: https://orcid.org/0000-0001-6638-7701)
Chirag Dhar (ORCID: https://orcid.org/0000-0002-7351-485X)
Vikram Paradkar (ORCID: https://orcid.org/0000-0001-9500-7237)
Aymaan Zaheer
Vijay Yerroju (ORCID: https://orcid.org/0000-0003-4192-3760)
Kamal Thammireddy (ORCID: https://orcid.org/0009-0007-7614-4026)
Amit Awasthi
Siddalingaiah Ningaiah (ORCID: https://orcid.org/0009-0006-6116-4959)
Chitta Sitaram Anjaneylu
Naveen Chander Reddy
Anil Kumar Pandey
Akshay Binayke
Shiva Narang

Institutions

Translational Health Science and Technology Institute (IN)
Guru Teg Bahadur Hospital (IN)
Biological E (India) (IN)
Asian Institute of Gastroenterology (IN)
St. Theresa’s Multi-Speciality Hospital (IN)
ESIC Hospital (IN)

Publication Details

Journal: IJID Regions
Published: 2026-01-02
DOI: https://doi.org/10.1016/j.ijregi.2025.100831
Primary Topic: SARS-CoV-2 and COVID-19 Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Corrigendum to ‘Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III cl

SubbaReddy Gunneri, Subhash Thuluva, Rammohan Reddy Mogulla, Chirag Dhar et al.

Jan 2, 2026

IJID Regions

SARS-CoV-2 and COVID-19 Research

article

Corrigendum to ‘Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III cl

SubbaReddy Gunneri, Subhash Thuluva, Rammohan Reddy Mogulla, Chirag Dhar, Vikram Paradkar, Aymaan Zaheer, Vijay Yerroju, Kamal Thammireddy, Amit Awasthi, Siddalingaiah Ningaiah, Chitta Sitaram Anjaneylu, Naveen Chander Reddy, Anil Kumar Pandey, Akshay Binayke, Shiva Narang

January 2, 2026article en

Abstract

No abstract available for this paper.

IJID RegionsVol. 18

Translational Health Science and Technology Institute (IN), Guru Teg Bahadur Hospital (IN), Biological E (India) (IN), Asian Institute of Gastroenterology (IN), St. Theresa’s Multi-Speciality Hospital (IN), ESIC Hospital (IN)

Good health and well-being

Openalex Percentile: Top 100%

SARS-CoV-2 and COVID-19 Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Corrigendum to ‘Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III cl — SubbaReddy Gunneri, Subhash Thuluva, et al. · IJID Regions (2026) | TGRS Research Map | TGRS